These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22493979)

  • 21. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
    Kathawala RJ; Gupta P; Ashby CR; Chen ZS
    Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy.
    To KKW; Huang Z; Zhang H; Ashby CR; Fu L
    Drug Resist Updat; 2024 Mar; 73():101058. PubMed ID: 38277757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversing multidrug resistance by tyrosine kinase inhibitors.
    He M; Wei MJ
    Chin J Cancer; 2012 Mar; 31(3):126-33. PubMed ID: 22237041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
    Karthikeyan S; Hoti SL
    Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Understanding of Interactions between Nanoparticles and ABC Transporters in Cancer Cells.
    Yin J; Deng X; Zhang J; Lin J
    Curr Med Chem; 2018; 25(42):5930-5944. PubMed ID: 29542407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP binding cassette transporters and cancer: revisiting their controversial role.
    Sharma P; Singh N; Sharma S
    Pharmacogenomics; 2021 Dec; 22(18):1211-1235. PubMed ID: 34783261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.
    Wu CP; Calcagno AM; Ambudkar SV
    Curr Mol Pharmacol; 2008 Jun; 1(2):93-105. PubMed ID: 19079736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
    Borowski E; Bontemps-Gracz MM; Piwkowska A
    Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs].
    Bogush TA; Konukhova AV; Ravcheeva AB; Zabotina TN; Kadagidze ZG; Bogush EA; Komov DV; Polotskiĭ BE; Laktionov KK; Davydov MI
    Antibiot Khimioter; 2003; 48(10):11-5. PubMed ID: 15004974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.
    Wang JQ; Wu ZX; Yang Y; Teng QX; Li YD; Lei ZN; Jani KA; Kaushal N; Chen ZS
    J Evid Based Med; 2021 Sep; 14(3):232-256. PubMed ID: 34388310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.
    Shukla S; Wu CP; Ambudkar SV
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):205-23. PubMed ID: 18248313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of ABC transporters in clinical practice.
    Leonard GD; Fojo T; Bates SE
    Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressors as multidrug resistance reversal agents.
    Morjani H; Madoulet C
    Methods Mol Biol; 2010; 596():433-46. PubMed ID: 19949935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.